| Literature DB >> 28163836 |
Masoumeh Sadeghi1, Hamidreza Roohafza1, Masoud Pourmoghaddas1, Omid Behnamfar1, Zahra Pourmoghaddas1, Ebrahim Heidari1, Zahra Mahjoor1, Mehdi Mousavi1, Ahmad Bahonar1, Nizal Sarrafzadegan1.
Abstract
AIM: To evaluate the prevalence of salt sensitivity and the impact of cardiometabolic and psychological characteristics on salt sensitivity in normotensive population.Entities:
Keywords: Cardiovascular disease risk factors; Salt sensitivity
Year: 2017 PMID: 28163836 PMCID: PMC5253194 DOI: 10.4330/wjc.v9.i1.47
Source DB: PubMed Journal: World J Cardiol
Baseline demographic, cardiometabolic and psychological characteristics of participants with respect to salt sensitivity
| Sex (male) (%) | 55 (73.3) | 45 (80.4) | 0.349 |
| Age (yr) (mean ± SD) | 25.23 ± 4.68 | 26.36 ± 6.91 | 0.272 |
| Family history of HTN (y/ | 22 (29.3) | 16 (28.6) | 0.995 |
| Family history of CAD (y/ | 7 (9.3) | 6 (10.7) | 0.770 |
| Regular physical activity (y/ | 30 (40.0) | 19 (33.9) | 0.522 |
| Current smoker (y/ | 12 (16.0) | 8 (14.3) | 0.865 |
| Weight (kg) (mean ± SD) | 68.21 ± 13.05 | 71.16 ± 12.33 | 0.193 |
| Body mass index (kg/m | 22.75 ± 2.71 | 23.71 ± 2.93 | 0.057 |
| Waist circumference (cm) (mean ± SD) | 81.54 ± 8.96 | 82.86 ± 8.41 | 0.404 |
| Hip circumference (cm) (mean ± SD) | 96.97 ± 5.90 | 97.38 ± 5.77 | 0.698 |
| Waist to hip ratio (mean ± SD) | 0.83 ± 0.06 | 0.84 ± 0.05 | 0.346 |
| Waist to height ratio (mean ± SD) | 0.47 ± 0.04 | 0.48 ± 0.49 | 0.382 |
| Fasting blood sugar (mg/dL) (mean ± SD) | 79.71 ± 6.16 | 82.64 ± 10.74 | 0.072 |
| Total cholesterol (mg/dL) (mean ± SD) | 156.54 ± 28.70 | 164.66 ± 26.64 | 0.109 |
| High-density lipoprotein cholesterol (mg/dL) (mean ± SD) | 46.23 ± 11.90 | 44.09 ± 12.23 | 0.327 |
| Low-density lipoprotein cholesterol (mg/dL) (mean ± SD) | 82.56 ± 21.27 | 90.05 ± 17.49 | 0.038 |
| Triglyceride (mg/dL) (mean ± SD) | 136.75 ± 97.26 | 145.32 ± 75.93 | 0.594 |
| Uric acid (mg/dL) (mean ± SD) | 6.91 ± 6.57 | 6.42 ± 1.56 | 0.597 |
| Sodium (mg/dL) (mean ± SD) | 140.30 ± 2.42 | 140.46 ± 2.39 | 0.699 |
| Potassium (mg/dL) (mean ± SD) | 4.38 ± 0.53 | 4.34 ± 0.34 | 0.662 |
| Blood urea nitrogen (mg/dL) (mean ± SD) | 12.56 ± 3.72 | 13.73 ± 3.63 | 0.077 |
| Creatinine (mg/dL) (mean ± SD) | 0.92 ± 0.12 | 0.96 ± 0.10 | 0.067 |
| Depression score (mean ± SD) | 4.00 ± 2.66 | 3.25 ± 2.15 | 0.095 |
| Anxiety score (mean ± SD) | 3.73 ± 3.18 | 3.08 ± 3.25 | 0.161 |
P value obtained from χ2;
P value obtained from t-test;
P value obtained from Man-Whitney. HTN: Hypertension; CAD: Coronary artery disease.
Crude, age and sex-adjusted logistic regression analysis with salt sensitivity as an outcome
| Total cholesterol (mg/dL) | 1.01 (1.00-1.02) | 0.11 | 1.01 (1.00-1.03) | 0.12 |
| Triglyceride (mg/dL) | 1.01 (1.00-1.01) | 0.59 | 1.00 (1.00-1.01) | 0.87 |
| High-density lipoprotein cholesterol (mg/dL) | 0.99 (0.96-1.02) | 0.33 | 0.99 (0.96-1.02) | 0.45 |
| Low-density lipoprotein cholesterol (mg/dL) | 1.02 (1.01-1.04) | 0.04 | 1.02 (1.01-1.04) | 0.04 |
| Fasting blood sugar (mg/dL) | 1.04 (1.00-1.09) | 0.06 | 1.04 (0.99-1.09) | 0.14 |
| Sodium (mg/dL) | 1.06 (0.97-1.04) | 0.35 | 1.03(0.98-1.05) | 0.37 |
| Potassium (mg/dL) | 1.05 (0.99-1.07) | 0.51 | 1.06(0.98-1.06) | 0.41 |
| Body mass index (kg/m2) | 1.14 (1.00-1.28) | 0.06 | 1.12 (0.97-1.28) | 0.13 |
| Waist circumference (cm) | 1.02 (0.98-1.06) | 0.40 | 1.02 (0.97-1.06) | 0.49 |
| Waist to hip ratio | 1.19 (0.83-1.69) | 0.34 | 1.16 (0.76-1.79) | 0.48 |
| Regular physical activity (y/ | 0.79 (0.38-1.64) | 0.52 | 0.85 (0.39-1.82) | 0.66 |
| Smoking (y/ | 1.07 (0.95-1.15) | 0.40 | 1.08 (0.97-1.25) | 0.47 |
| Depression (y/ | 1.14 (0.98-1.32) | 0.06 | 1.15 (1.00-1.34) | 0.04 |
| Family history of HTN (y/ | 1.19 (0.37-3.85) | 0.77 | 1.28 (0.35-4.76) | 0.70 |
HTN: Hypertension.
Figure 1Means of systolic blood pressure mmHg (vertical axes), measurements at: (1) baseline; (2) 2 h after saline infusion; (3) before sodium and water depletion; and (4) after sodium and water depletion (horizontal axes), among individuals without or with at least one cardiovascular risk factor.